Form 8-K - Current report:
SEC Accession No. 0001213900-21-059448
Filing Date
2021-11-15
Accepted
2021-11-15 16:45:46
Documents
15
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150503-8k_optimizerx.htm   iXBRL 8-K 33373
2 TRANSCRIPT OF OPTIMIZERX CORPORATION CONFERENCE CALL ON NOVEMBER 9, 2021 ea150503ex99-1_optimizerx.htm EX-99.1 96904
3 GRAPHIC ex99-1_001.jpg GRAPHIC 126727
4 GRAPHIC ex99-1_002.jpg GRAPHIC 38557
  Complete submission text file 0001213900-21-059448.txt   554900

Data Files

Seq Description Document Type Size
5 XBRL LABEL FILE oprx-20211109_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20211109_pre.xml EX-101.PRE 22363
7 XBRL SCHEMA FILE oprx-20211109.xsd EX-101.SCH 3031
8 EXTRACTED XBRL INSTANCE DOCUMENT ea150503-8k_optimizerx_htm.xml XML 3599
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 211411787
SIC: 7389 Services-Business Services, NEC